PainChek receives $1.123 million R&D tax incentive refund
Key points
- $1.123 million R&D tax incentive refund received
- Strengthens cash position and supports product development
- Includes development of PainChek Adult and Infant algorithms
- Supports US market entry and expansion for children
Full summary
PainChek Ltd, developer of the world's first AI-powered pain assessment and monitoring application, has announced the receipt of a $1.123 million research and development (R&D) tax incentive refund for the 2025 financial year. This refund, provided by the Australian Government's R&D Tax Incentive program, relates to eligible R&D activities undertaken by PainChek, including the development of its Adult and Infant algorithms and validation activities supporting its entry into the US market and the expansion of its technology for use in children.
Summary generated by a large language model. Please interpret with care.